Independent investing research and personal finance for IrelandUnderstand. Decide. Compound.

Health3 min read

How does semaglutide work? Ozempic, Wegovy and Rybelsus explained

Ozempic, Wegovy and Rybelsus share an active ingredient. Learn how semaglutide affects appetite and blood glucose, and how the products differ.

Ozempic semaglutide injection penHealth / The Compound journal

Photo: Dennis Sylvester Hurd, 2024 · CC0 1.0 · cropped · Illustrative image.

Semaglutide is the active ingredient in Ozempic, Wegovy and Rybelsus. It activates a receptor used by GLP-1, a hormone involved in appetite and blood glucose regulation. Each product has its own formulation, indication and instructions. This guide covers the main adult EU uses and links to separate coverage of Irish access and costs. EMA: Ozempic · EMA: Wegovy · EMA: Rybelsus

The Science Behind the Drug

When you eat, the gut releases glucagon-like peptide-1, or GLP-1. Semaglutide is a GLP-1 receptor agonist, meaning it attaches to that receptor and activates it. The same receptor is involved in several processes, so the effects depend on where the signal is received. EMA product information, section 5.1

  • Pancreas: When blood glucose is elevated, semaglutide helps insulin release and can reduce the release of glucagon, a hormone that raises blood glucose.
  • Brain: GLP-1 signalling in areas involved in appetite can increase fullness and reduce hunger and food intake.
  • Stomach: Semaglutide can slow stomach emptying. The product information describes this alongside the effects on appetite and pancreatic hormones. EMA product information, section 5.1

Ozempic, Wegovy and Rybelsus compared

Product Form in EMA product information Main authorised adult use
Ozempic Weekly injection Type 2 diabetes
Wegovy Weekly injection or daily tablet, depending on the formulation Weight management in eligible adults
Rybelsus Daily tablet Type 2 diabetes

The EMA documents describe the EU authorisation. Local stock and reimbursement are separate questions. Use the exact product on your prescription and check with your prescriber before switching between products. EMA: Ozempic · EMA: Wegovy · EMA: Rybelsus

How do the tablets get absorbed?

Wegovy tablets and Rybelsus contain salcaprozate sodium (SNAC), which helps semaglutide cross the stomach lining. Food can reduce absorption of oral semaglutide, so the tablet leaflets include fasting instructions. The products are authorised for different uses. See oral GLP-1 medicines in Ireland for the comparison with Foundayo and how Irish access is confirmed. EMA Wegovy product information, section 5.2 · EMA Rybelsus product information

What should you discuss with your prescriber?

Nausea, diarrhoea, vomiting and constipation can occur. Seek urgent medical advice for severe, persistent abdominal pain, which can be a sign of pancreatitis. Tell your care team if you take insulin or a sulfonylurea, are planning pregnancy, or are due to have an operation with general anaesthesia or deep sedation. The product leaflet covers these situations and other precautions in more detail. EMA Wegovy prescribing information and leaflet

Keep formulation, indication and outcome attached to every result

A trial of injectable semaglutide for weight management answers a different question from a trial of oral semaglutide in type 2 diabetes. Check the formulation and population before comparing a percentage change in body weight with a change in HbA1c. Even within one outcome, follow-up length, background treatments and how discontinuations were handled matter. Use the product-information study summaries to check which evidence applies to each brand. EMA Wegovy information · EMA Rybelsus information

Take a product and monitoring checklist to the appointment

Bring the brand, device or tablet, why it was started and dates of any recent changes. For the oral form, describe how you take it in practice. That gives the pharmacist a chance to discuss absorption and other medicines you take at the same time. Mention insulin or other diabetes drugs that could contribute to low glucose, persistent vomiting or difficulty keeping fluids down, and any upcoming procedure involving anaesthesia or deep sedation. EMA Wegovy information

Read the oral GLP-1 comparison for more on the different formulations. Ask the prescriber or pharmacist about the current supply and instructions before making any change.

Read more on Compound Health

YOUR PRIVACY

Help us understand what gets read.

With your permission, anonymous Google Analytics measurements tell us which articles are useful. We do not send calculator entries or form values. You can decline and still read everything.